273 related articles for article (PubMed ID: 28656074)
1. Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.
Moravec R; Divi R; Verma M
World J Gastrointest Oncol; 2017 Jun; 9(6):235-250. PubMed ID: 28656074
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?
Moutinho-Ribeiro P; Macedo G; Melo SA
Front Endocrinol (Lausanne); 2018; 9():779. PubMed ID: 30671023
[TBL] [Abstract][Full Text] [Related]
3. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
4. Detecting ovarian cancer using extracellular vesicles: progress and possibilities.
Carollo E; Paris B; Samuel P; Pantazi P; Bartelli TF; Dias-Neto E; Brooks SA; Pink RC; Carter DRF
Biochem Soc Trans; 2019 Feb; 47(1):295-304. PubMed ID: 30700499
[TBL] [Abstract][Full Text] [Related]
5. Evidence for circulating cancer stem-like cells and epithelial-mesenchymal transition phenotype in the pleurospheres derived from lung adenocarcinoma using liquid biopsy.
Mirza S; Jain N; Rawal R
Tumour Biol; 2017 Mar; 39(3):1010428317695915. PubMed ID: 28347243
[TBL] [Abstract][Full Text] [Related]
6. Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer.
Kato S; Honda K
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32707720
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy in pancreatic cancer: the beginning of a new era.
Yadav DK; Bai X; Yadav RK; Singh A; Li G; Ma T; Chen W; Liang T
Oncotarget; 2018 Jun; 9(42):26900-26933. PubMed ID: 29928492
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review.
Xue J; Jia E; Ren N; Lindsay A; Yu H
Onco Targets Ther; 2019; 12():6665-6684. PubMed ID: 31692495
[TBL] [Abstract][Full Text] [Related]
9. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
11. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
[TBL] [Abstract][Full Text] [Related]
12. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
[TBL] [Abstract][Full Text] [Related]
13. [Aiming for zero blindness].
Nakazawa T
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
[TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression.
Chang L; Ni J; Zhu Y; Pang B; Graham P; Zhang H; Li Y
Theranostics; 2019; 9(14):4130-4140. PubMed ID: 31281536
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of circulating ADH and MIC-1 as diagnostic markers in Egyptian patients with pancreatic cancer.
Mohamed AA; Soliman H; Ismail M; Ziada D; Farid TM; Aref AM; Al Daly ME; Abd Elmageed ZY
Pancreatology; 2015; 15(1):34-9. PubMed ID: 25464937
[TBL] [Abstract][Full Text] [Related]
16.
Wang ZY; Ding XQ; Zhu H; Wang RX; Pan XR; Tong JH
Front Oncol; 2019; 9():1295. PubMed ID: 31850201
[No Abstract] [Full Text] [Related]
17. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
18. Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System.
Pessolano E; Belvedere R; Bizzarro V; Franco P; Marco I; Porta A; Tosco A; Parente L; Perretti M; Petrella A
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518142
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
